Paul trained in Paediatric Allergy and Immunology at the Children’s Hospital at Westmead, Sydney (where he was mentored by Andrew Kemp and Dianne Campbell) and Great Ormond Street Hospital, London. He is a graduate of Oxford University and the University of London, and undertook a PhD investigating the immunopharmacology of allergic rhinitis under John Foreman (University College London) and Glenis Scadding (Royal National Throat Nose & Ear Hospital, London).
Paul is currently MRC Clinician Scientist in Paediatric Allergy & Immunology within the MRC & Asthma UK Centre in Allergic Mechanisms of Asthma at Imperial College London, where his sponsors include John Warner, Stephen Durham and Gideon Lack. Paul is PI on a grant investigating mechanisms of food-triggered anaphylaxis. His other research interests include seafood allergy, allergic rhinitis and allergen avoidance. He teaches on the MSc in Allergy at Imperial College, and has lectured at a number of national and international meetings.
He has clinical commitments as an Honorary Consultant in Paediatric Allergy & Immunology at a number of specialist tertiary centres in London, including St Mary’s Hospital (Paddington) and the Evelina Children’s Hospital. He also holds an Honorary Lectureship at the University of Sydney where he teaches on the Masters of Medicine programme. He is a Fellow of the Royal Australasian College of Physicians.
Paul is an active member of the BSACI Paediatric Allergy Group, where he has led the project to institute nationwide Allergy Action Plans for children with life-threatening allergies, alongside Dr George Du Toit (see http://www.bsaci.org/about/pag-allergy-action-plans-for-children). He is also a member of the Health Advisory Board for Allergy UK, a patient support charity (http://www.allergyuk.org).
et al., International consensus guidelines for the diagnosis and management of food protein-induced Enterocolitis syndrome, Journal of Allergy and Clinical Immunology, ISSN:1097-6825
et al., 2017, Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis, Journal of Allergy and Clinical Immunology, Vol:140, ISSN:0091-6749, Pages:750-+
et al., 2017, Fatal Anaphylaxis: Mortality Rate and Risk Factors, Journal of Allergy and Clinical Immunology-in Practice, Vol:5, ISSN:2213-2198, Pages:1169-1179
et al., 2017, Striking the balance between primary prevention of allergic disease and optimal infant growth and nutrition., Pediatr Allergy Immunol
et al., 2017, Mast cell activation test distinguishes between sensitisation and clinical reactivity with improved diagnostic characteristics compared to other diagnostic techniques including basophil activation, Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, WILEY, Pages:139-140, ISSN:0105-4538